A Phase II Study of Modulated-Capecitabine and Docetaxel in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Por Bertino, Erin M., Bekaii-Saab, Tanios, Fernandez, Soledad, Diasio, Robert B., Karim, Nagla A., Otterson, Gregory A., Villalona-Calero, Miguel A.
Publicado em 2012

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

Por Karim, Nagla A, Bui, Hai, Pathrose, Peterson, Starnes, Sandra, Patil, Ninad, Shehata, Mahmoud, Mostafa, Ahmed, Rao, MB, Zarzour, Ahmad, Anderson, Marshall
Publicado no Clin Med Insights Oncol (2014)

Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis

Por Li, Chenggang, Li, Na, Liu, Xiaolei, Zhang, Erik Y., Sun, Yang, Masuda, Kouhei, Li, Jing, Sun, Julia, Morrison, Tasha, Li, Xiangke, Chen, Yuanguang, Wang, Jiang, Karim, Nagla A., Zhang, Yi, Blenis, John, Reginato, Mauricio J., Henske, Elizabeth P., Yu, Jane J.
Publicado no JCI Insight (2016)